Thomson Reuters (TRI) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
2 Feb, 2026Executive summary
Q2 2024 delivered 6% organic revenue growth, with the Big Three segments up 8% organically and strong momentum in key products and international markets.
Full-year 2024 revenue outlook raised to the high end of prior ranges, now expecting 6.5–7.0% organic growth and 8–8.5% for the Big Three.
Continued strong customer interest in generative AI offerings, with new product launches such as CoCounsel Drafting and Checkpoint Edge with CoCounsel.
Completed monetization of LSEG stake for $8.3 billion and finished a $1 billion share repurchase program in Q2.
Robust liquidity and capital capacity support further M&A and shareholder returns, with $8B capital capacity estimated by 2026.
Financial highlights
Q2 2024 revenues rose 6% year-over-year to $1.74B; adjusted EBITDA fell 2% to $646M, with a 300bp margin decline to 37.1%.
Adjusted EPS was $0.85, down from $0.88 in the prior year; diluted EPS was $1.86, down 2% year-over-year.
Free cash flow for H1 2024 was $812M, up 11% from the prior year; Q2 free cash flow was $541M, down 9%.
Operating profit for Q2 was $415M, down 50% year-over-year due to prior-year gain on Elite sale.
Cash flow from operations increased 2% to $705M in Q2.
Outlook and guidance
2024 total revenue growth now expected at approximately 7%, organic revenue growth at 6.5%.
Big Three revenue growth guidance raised to 8.5% total and 8% organic.
Adjusted EBITDA margin guidance reaffirmed at approximately 38% for 2024; free cash flow expected at ~$1.8B.
Q3 2024 organic revenue growth expected at 6% with an adjusted EBITDA margin of 34%.
Interest expense outlook reduced to $125–$145M due to earlier LSEG monetization and higher interest rates on cash balances.
Latest events from Thomson Reuters
- Fiduciary-grade AI, innovation, and disciplined capital allocation drive double-digit growth.TRI
BofA Securities 2026 Information & Business Services Conference12 Mar 2026 - Strong organic growth, margin expansion, and capital returns set the stage for 2026 targets.TRI
Q4 20255 Feb 2026 - Significant AI investment and innovation drive product enhancements and sustained market demand.TRI
CIBC Technology & Innovation Conference 13.03 Feb 2026 - Strong financials, AI innovation, and all board resolutions passed; AI governance proposal rejected.TRI
AGM 20253 Feb 2026 - Strong growth, AI investment, and all resolutions passed with high shareholder support.TRI
AGM 20241 Feb 2026 - Q3 revenue up 8% and 2024 outlook raised, led by AI-driven growth and strong core segments.TRI
Q3 202416 Jan 2026 - $200M annual GenAI investment fuels growth, integration, and market leadership in legal and tax.TRI
J.P. Morgan Ultimate Services Investor Conference 202414 Jan 2026 - Organic revenue up 7%, margin 38.2%, AI adoption strong, and 2025 outlook robust.TRI
Q4 20249 Jan 2026 - Q1 organic revenue up 6%, "Big 3" segments strong, 2025 outlook and dividend raised.TRI
Q1 202525 Dec 2025